FR1421130A - Process for the preparation of aminocarboxamides - Google Patents

Process for the preparation of aminocarboxamides

Info

Publication number
FR1421130A
FR1421130A FR2532A FR2532A FR1421130A FR 1421130 A FR1421130 A FR 1421130A FR 2532 A FR2532 A FR 2532A FR 2532 A FR2532 A FR 2532A FR 1421130 A FR1421130 A FR 1421130A
Authority
FR
France
Prior art keywords
aminocarboxamides
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR2532A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of FR1421130A publication Critical patent/FR1421130A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR2532A 1964-01-27 1965-01-20 Process for the preparation of aminocarboxamides Expired FR1421130A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH93064 1964-01-27

Publications (1)

Publication Number Publication Date
FR1421130A true FR1421130A (en) 1965-12-10

Family

ID=4198470

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2532A Expired FR1421130A (en) 1964-01-27 1965-01-20 Process for the preparation of aminocarboxamides

Country Status (5)

Country Link
BE (1) BE658748A (en)
DE (1) DE1493824A1 (en)
ES (1) ES308571A1 (en)
FR (1) FR1421130A (en)
NL (1) NL6414901A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005524648A (en) * 2002-02-22 2005-08-18 ニュー リバー ファーマシューティカルズ インコーポレイテッド Novel sustained-release pharmaceutical compounds to prevent abuse of controlled substances
US7105486B2 (en) 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
JP2007500242A (en) * 2003-05-29 2007-01-11 ニュー リバー ファーマシューティカルズ インコーポレイテッド Abuse-resistant amphetamine compounds
US7375083B2 (en) 2003-09-30 2008-05-20 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US7427600B2 (en) 2000-08-22 2008-09-23 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7655630B2 (en) 2002-02-22 2010-02-02 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7776917B2 (en) 2006-12-11 2010-08-17 Mickle Travis C Non-standard amino acid conjugates of amphetamine and processes for making and using the same
US8106016B2 (en) 2003-09-30 2012-01-31 Shire Llc Compounds and compositions for prevention of overdose of oxycodone
US8343927B2 (en) 2001-08-22 2013-01-01 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2710617T3 (en) * 2010-04-21 2019-04-26 Signature Therapeutics Inc Compositions comprising enzymatically cleavable amphetamine prodrugs and inhibitors thereof
US8779191B2 (en) * 2010-12-20 2014-07-15 Cambrex Charles City, Inc. Methods and compositions for preparing lisdexamfetamine and salts thereof
EP3459538B1 (en) * 2017-09-20 2020-05-06 Sandoz AG Crystalline salts of a dextroamphetamine prodrug

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427600B2 (en) 2000-08-22 2008-09-23 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US8343927B2 (en) 2001-08-22 2013-01-01 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US7674774B2 (en) 2002-02-22 2010-03-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7723305B2 (en) 2002-02-22 2010-05-25 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7622441B2 (en) 2002-02-22 2009-11-24 Shire Llc Sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7655630B2 (en) 2002-02-22 2010-02-02 Shire Llc Abuse-resistant amphetamine prodrugs
US7659254B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7718619B2 (en) 2002-02-22 2010-05-18 Shire Llc Abuse-resistant amphetamine prodrugs
US7662788B2 (en) 2002-02-22 2010-02-16 Shire Llc Abuse-resistant amphetamine prodrugs
US7671030B2 (en) 2002-02-22 2010-03-02 Shire Llc Abuse-resistant amphetamine prodrugs
US7671031B2 (en) 2002-02-22 2010-03-02 Shire Llc Abuse-resistant amphetamine prodrugs
JP2005524648A (en) * 2002-02-22 2005-08-18 ニュー リバー ファーマシューティカルズ インコーポレイテッド Novel sustained-release pharmaceutical compounds to prevent abuse of controlled substances
US7678770B2 (en) 2002-02-22 2010-03-16 Shire Llc Abuse-resistant amphetamine prodrugs
US7678771B2 (en) 2002-02-22 2010-03-16 Shire Llc Abuse-resistant amphetamine prodrugs
US7687467B2 (en) 2002-02-22 2010-03-30 Shire Llc Abuse-resistant amphetamine prodrugs
US7687466B2 (en) 2002-02-22 2010-03-30 Shire Llc Abuse-resistant amphetamine prodrugs
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7713936B2 (en) 2002-02-22 2010-05-11 Shire Llc Abuse-resistant amphetamine prodrugs
US7662787B2 (en) 2003-05-29 2010-02-16 Shire Llc Abuse resistant lysine amphetamine compounds
JP4898445B2 (en) * 2003-05-29 2012-03-14 シャイア エルエルシー Abuse-resistant amphetamine compounds
JP2007500242A (en) * 2003-05-29 2007-01-11 ニュー リバー ファーマシューティカルズ インコーポレイテッド Abuse-resistant amphetamine compounds
US7223735B2 (en) 2003-05-29 2007-05-29 New River Pharmaceuticals Inc. Abuse resistant lysine amphetamine compounds
US7375083B2 (en) 2003-09-30 2008-05-20 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US8106016B2 (en) 2003-09-30 2012-01-31 Shire Llc Compounds and compositions for prevention of overdose of oxycodone
US7776917B2 (en) 2006-12-11 2010-08-17 Mickle Travis C Non-standard amino acid conjugates of amphetamine and processes for making and using the same
US8101661B2 (en) 2006-12-11 2012-01-24 Kempharm, Inc. Polar hydrophilic prodrugs and non-standard amino acid conjugates of amphetamine and other stimulants and processes for making and using the same

Also Published As

Publication number Publication date
DE1493824A1 (en) 1969-05-22
ES308571A1 (en) 1966-06-01
NL6414901A (en) 1965-07-28
BE658748A (en) 1965-07-26

Similar Documents

Publication Publication Date Title
FR1421130A (en) Process for the preparation of aminocarboxamides
FR1429549A (en) Process for the preparation of organohalosilanes
FR1434059A (en) Process for the preparation of tertiary oxyamines
FR1448790A (en) Process for the preparation of alpha-monochloro-nu, nu-dialkoyl-aceto-acetamides
FR1509368A (en) Process for the preparation of hydrindacenes
FR1506790A (en) Process for the preparation of elastomers
FR1436391A (en) Process for the preparation of nu-substituted amides
FR1531929A (en) Process for the preparation of alpha-6-deoxytetracyclines
FR1511342A (en) Process for the preparation of alpha-nitro-ketones
FR1450082A (en) Process for the preparation of hydroxylamine
FR1413955A (en) Process for the preparation of 4-amino-5-halogeno-6-pyridazones
FR1515929A (en) Process for the preparation of antibiotics
FR1434858A (en) Process for the preparation of urea
FR1454183A (en) Process for the preparation of carbonylhalosulfenyl halides
CH438365A (en) Process for the preparation of alkylene monothiocarbonates
FR1438705A (en) Process for the preparation of omega-lactams
FR1363643A (en) Process for the preparation of aminoisoxazoles
FR1481040A (en) Process for the preparation of primary amines
FR1414256A (en) Process for the preparation of arylboranes
FR1411617A (en) Process for the preparation of epsilon-caprolactones
FR1426757A (en) Process for the preparation of an n-alkyl-alpha-pyrrolidone
FR1443677A (en) Process for the preparation of inverted emulsions
FR1429626A (en) Process for the preparation of cyclic ethers
FR1438889A (en) Process for the preparation of oxazoles
FR1488919A (en) Process for the preparation of alpha-amino-omega-lactams